Oncology - European Medical Journal

This site is intended for healthcare professionals

Continue

Oncology

Filter
EMJ
13 Jul 2017

ASSIST-FL – Primary Outcome: Interview with Prof. Jurczak

In this interview, Professor Wojciech Jurczak presents and discusses the primary results of ASSIST-FL, the confirmatory, PhIII randomised, double blinded…
EMJ
15 Jun 2017

Prof. Marie-Pia d’Ortho Interview

Interview with Prof. Marie-Pia d’Ortho.
17 Jun 2016

Personalised screening for breast cancer care

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from…
EMJ
14 Jun 2016

Translating genomics to precision medicine for breast cancer care: Ongoing clinical studies

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
EMJ
14 Jun 2016

Identifying breast cancer patients who can be spared chemotherapy, evidence from recent studies

The Oncotype DX® 21-gene Recurrence Score® result stratifies patients with breast cancer into low-, intermediate- and high-risk groups that correspond to…
EMJ
14 Jun 2016

Impact of phase 3 PlanB trial on evidence-based clinical practice for breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
EMJ
14 Jun 2016

5-year outcomes from PlanB: Phase 3 trial of 21-gene Recurrence Score® result in breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
EMJ
14 Jun 2016

Overview of prospective phase 3 PlanB trial of 21-gene Recurrence Score® result in breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
14 Jun 2016

Defining factors that can predict neoadjuvant chemotherapy response in breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from the…
14 Jun 2016

Genetically determining susceptibility of breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Douglas Easton, PhD, from the…
14 Jun 2016

Surgical considerations after neoadjuvant treatment for breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital…
14 Jun 2016

Individualisation of breast cancer therapy

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital…
14 Jun 2016

Opportunities for improved outcomes in breast cancer patients

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from…
14 Jun 2016

2005–2015 global analysis of advanced breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD…
14 Jun 2016

Imaging biomarkers as a predictive tool in breast cancer management

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from the…
14 Jun 2016

Abstracts from the 10th European Breast Cancer Conference

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the…
14 Jun 2016

Checkpoint inhibitors for triple-negative breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…
14 Jun 2016

Precision medicine for breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…
14 Jun 2016

Highlights of the 10th European Cancer Conference (EBCC-10) by Dr Giuseppe Curigliano

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…
14 Jun 2016

Themes of the 10th European Breast Cancer Conference (EBCC-10)

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the…
EMJ
14 Jun 2016

Understanding the unique aspects of immunotherapy for lung cancer

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD, from the LungenClinic Grosshansdorf…
14 Jun 2016

Immunotherapy for head and neck cancer

At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD, from Hannover Medical School, Hannover…
14 Jun 2016

Improving the treatment of advanced renal cell carcinoma

At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD, from Hannover Medical School, Hannover…
14 Jun 2016

Predictive biomarkers for immunotherapy in non-small cell lung cancer

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD, from the LungenClinic Grosshansdorf…
EMJ
14 Jun 2016

Next-generation sequencing to guide treatment decision-making

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm…
EMJ
14 Jun 2016

Introducing next-generation sequencing into the clinical care of cancer

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm…
EMJ
14 Jun 2016

Early versus delayed use of tyrosine kinase inhibitors for thyroid cancer

Recent advances in the biological understanding of thyroid cancer have led to the development of targeted therapies, such as the tyrosine kinase…
EMJ
14 Jun 2016

Updating the treatment algorithm for metastatic melanoma

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Axel Hauschild, MD, from University of Kiel, Kiel, Germany…
EMJ
14 Jun 2016

Changing the treatment landscape of metastatic melanoma

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Axel Hauschild, MD, from University of Kiel, Kiel, Germany…
EMJ
14 Jun 2016

Clinical decision-making for pancreatic cancer

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Thomas Seufferlein, MD, from University of Ulm, Ulm, Germany…
EMJ
14 Jun 2016

The significance of BRCA mutations in pancreatic cancer

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Thomas Seufferlein, MD, from University of Ulm, Ulm, Germany…
EMJ
14 Jun 2016

Treatment of pancreatic cancer: Overview of the continued progress

Pancreatic cancer is a leading cause of cancer-related deaths in developed countries. At the German Cancer Congress 2016, held in Berlin, Germany, from…
EMJ
25 May 2016

KEYNOTE-010: Pembrolizumab versus docetaxel in advanced PD-L1-positive NSCLC

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…
EMJ
25 May 2016

ASCEND-2 and ASCEND-3 trials: Ceritinib in ALK-rearranged NSCLC with brain metastases

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…
EMJ
25 May 2016

Immune checkpoint inhibitors, durvalumab plus tremelimumab, for non-small cell lung cancer

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…
EMJ
25 May 2016

Immunotherapy for hepatocellular carcinoma

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Su Pin Choo, MBBS…
EMJ
25 May 2016

Phase 3 LUX-H&N1 trial: Afatinib versus methotrexate for head and neck squamous cell carcinoma

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Makoto Tahara, MD…
EMJ
25 May 2016

Endocrine therapy in pregnant women with breast cancer

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Sibylle Loibl, MD, PhD…
EMJ
25 May 2016

Olaparib and bevacizumab: On the horizon for treating ovarian cancer

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Suresh Kumarasamy, MBBS…
EMJ
25 May 2016

Tumour biomarker changes after neoadjuvant chemotherapy in breast cancer

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Sibylle Loibl, MD, PhD…
25 May 2016

From biologics to biosimilars

A biosimilar can be defined as a biological product that demonstrates no clinically meaningful differences to an approved biological product. At the…
19 Apr 2016

Canakinumab in the treatment of tumour necrosis factor receptor-associated periodic syndrome (TRAPS)

At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen…
EMJ
9 Mar 2016

Precision medicine for metastatic breast cancer

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Janice Tsang, MBBS…
EMJ
20 Feb 2016

Overview of a Phase I study of ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

Martin JS Dyer, MA, DPhil, FRCP, FRCPath from the University of Leicester, Leicester, UK, provides an overview of a Phase I study of ONO/GS-4059, a…
EMJ
5 Feb 2016

Roles of targeted therapy and immunotherapy for gastrointestinal cancer

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Atsushi Ohtsu, MD, PhD…
EMJ
5 Feb 2016

ESMO 2015 highlights: Putting ovarian cancer management into perspective

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Andrés Cervantes…
EMJ
5 Feb 2016

Defining ESMO Clinical Practice Guidelines at ESMO Asia 2015

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Andrés Cervantes, MD…
EMJ
5 Feb 2016

Phase 1b trial of durvalumab plus tremelimumab for advanced non-small cell lung cancer

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Johan Vansteenkiste…
We’ve noticed you’re accessing
from North/South America.